Establishment of an adverse effect prevention protocol on plasma exchange using fresh frozen plasma prior to ABO ‐incompatible living donor kidney transplantation at our hospital
Therapeutic Apheresis and Dialysis · 2024
DOI: 10.1111/1744-9987.14071 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Akihito Tanaka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Nagoya University Hospital, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: Kidney Transplantation, Hypersensitivity. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Introduction
Simple plasma exchange (PE) with fresh‐frozen plasma replacement allows antibody removal for ABO‐incompatible living donor kidney transplantation, but is associated with a high incidence of allergic reactions. We developed, implemented, and evaluated a protocol for safe preoperative PE.
Methods
The protocol comprised pretreatment (125 mg methylprednisolone infusion, 400 mg acetaminophen and 30 mg diphenhydramine orally) with a replacement fluid rate < 20 mL/min. Allergic reaction incidence was investigated in controls who underwent ABO‐incompatible living donor kidney transplantation between 2016 and March 2020 (group C) and patients who underwent the protocol and procedure between April 2020 and February 2023 (group N).
Results
Ten (group C) and 19 (group N) patients performed 11 and 30 sessions of PE, respectively. Allergic reactions occurred in 81.8% and 36.7% ( p = 0.014), respectively, with an odds ratio of the protocol was 0.056 (95% CI 0.0059–0.5380, P = 0.013).
Conclusion
Our protocol resulted in a significantly lower incidence of allergic reactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Nagoya University Hospital, Nagoya, Aichi, Japan.
- Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
- Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
ORCID-Profile: Akihito Tanaka, Kazuhiro Furuhashi
Zitieren
APA
Tanaka, A., Watanabe, Y., Furuhashi, K., Saito, S., Yasuda, Y., Kosugi, T., Sano, Y., Kato, M., & Maruyama, S. (2024). Establishment of an adverse effect prevention protocol on plasma exchange using fresh frozen plasma prior to ABO ‐incompatible living donor kidney transplantation at our hospital. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14071
Vancouver
Tanaka A, Watanabe Y, Furuhashi K, Saito S, Yasuda Y, Kosugi T, et al. Establishment of an adverse effect prevention protocol on plasma exchange using fresh frozen plasma prior to ABO ‐incompatible living donor kidney transplantation at our hospital. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14071
BibTeX
@article{Tanaka2024,
author = {Tanaka, Akihito and Watanabe, Yu and Furuhashi, Kazuhiro and Saito, Shoji and Yasuda, Yoshinari and Kosugi, Tomoki and Sano, Yuta and Kato, Masashi and Maruyama, Shoichi},
title = {Establishment of an adverse effect prevention protocol on plasma exchange using fresh frozen plasma prior to ABO ‐incompatible living donor kidney transplantation at our hospital},
journal = {Therapeutic Apheresis and Dialysis},
year = {2024},
doi = {10.1111/1744-9987.14071}
}
EUVIMED